CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 4 Open-market sale 10% owner sold 21,932 shares at $1.10 ($24,059)
- 4 Open-market sale 10% owner sold 60,730 shares at an average $1.02 ($62,193)
- 8-K Event Executive or director change
- 4 Open-market sale 10% owner sold 37,338 shares at an average $1.07 ($39,800)
- 4 Open-market sale 10% owner sold 25,000 shares at an average $1.09 ($27,320)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes SVP of Finance gave up 115 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 164 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
- 4 Shares withheld for taxes SVP of Finance gave up 1,392 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 2,363 shares (to pay taxes)
- 8-K Event Material agreement · New debt or obligation · Other events
- 8-K Event Executive or director change
- 4/A Grant or award CEO acquired 10,777 shares (grant or award)
- 4 Grant or award CEO acquired 11,654 shares (grant or award)
- 8-K Event Delisting notice · Executive or director change · Other events
- 4 Shares withheld for taxes CEO gave up 207 shares (to pay taxes)
- 4 Shares withheld for taxes SVP of Finance gave up 114 shares (to pay taxes)
Page 25 of 77 · 1,525 filings